Role of Glucagon-like Peptide-1 (GLP-1) receptor agonists versus DPP-4 inhibitors for alcohol and substance use disorders in improving HIV-related outcomes and providing health benefits in people living with HIV
Posted Date:
Jul 22, 2026
Jul 30, 2026
Awarded Date:
No Awarded Date
| SetAside Type | ||
| No Set aside used | ||
| Solicitation ID | Solicitation Title | Solicitation Office |
| 75N95026R0007 | Role of Glucagon-like Peptide-1 (GLP-1) receptor agonists versus DPP-4 inhibitors for alcohol and substance use disorders in improving HIV-related outcomes and providing health benefits in people living with HIV | |
| Synopsis | ||
|
COMBINED SYNOPSIS / SOLICITATION (COMPETITIVE) Title: Role of Glucagon-like Peptide-1 (GLP-1) receptor agonists versus DPP-4 inhibitors for alcohol and substance use disorders in improving HIV-related outcomes and providing health benefits in people living with HIV (i) This is a combined synopsis/solicitation for commercial items. This announcement constitutes the only solicitation; a written solicitation will not be issued. (ii) The solicitation number is 75N95026R0007. This solicitation is issued as a request for proposal (RFP). (iii) This solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular FAC 2026-01. (iv) This requirement .... Read More |
||
| Office Location | Agency Name | Solicitation Base Posting Type |
| NATIONAL INSTITUTES OF HEALTH | Combined Synopsis/Solicitation | |
